Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the efficacy and safety of the use of Stilnox CR in Mexican patients with chronic
insomnia at the prescription conditions of daily practice
Secondary Objective:
To evaluate the satisfaction of the patient with chronic insomnia with Stilnox CR over an as
needed basis.